← All organizations

Capstone Therapeutics

For profitWebsite ↗

Also known as: Celerity Pharmaceuticals | CELERITY PHARMS | Gage Development Company, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Oct 19, 2022

Defunct as of Mar 28, 2020

Timeline

1980s

Jun 1, 1987
Capstone Therapeutics— Founded

2010s

Jan 25, 2019
bendamustine— Marketing Organization

2020s

Mar 28, 2020
Capstone Therapeutics— Defunct

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (8)

NCT03717506Lead sponsorPhase 3Oct 3, 2018
NCT03091777Lead sponsorPhase 3Mar 10, 2017
NCT02952898Lead sponsorPhase 3Oct 1, 2016
NCT00892723Lead sponsorPhase 2May 1, 2009
NCT00825916Lead sponsorPhase 2Mar 1, 2009
NCT00811577Lead sponsorPhase 2Jan 1, 2009
NCT00131482Study chairPhase 2Nov 1, 2004
NCT00131482Lead sponsorPhase 2Nov 1, 2004

Details

Founded: Tempe, AZ, US Jun 1, 1987
Last known activity: Oct 19, 2022